Lydia Sauer is an Ophthalmology physician. OpenAlex indexes 75 publications with 1,395 citations (h-index 20).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
65 S Mario Capecchi Dr
Salt Lake City, UT 841320005
Telephone
801-581-2352Provider last certified this registry record 22 Jul 2024.
Industry payments
20 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Bausch & Lomb Americas Inc.Program year20255 payments
- Regeneron Healthcare Solutions, Inc.Program year20253 payments
- ANI Pharmaceuticals, Inc.Program year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
83%Corticosteroid46.2%Prednisolone Acetate100%Part D≥91 patientsQuinolone Antimicrobial23.9%Ofloxacin100%Part D≥55 patients+ 2 more classes in this area
Musculoskeletal
12.1%Cyclooxygenase Inhibitor12.1%Ketorolac Tromethamine100%Part D≥22 patientsAnti-infectives
4.9%Fluoroquinolone Antibacterial4.9%Moxifloxacin100%Part D≥12 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- iPSC–derived retinal pigmented epithelial cells from patients with macular telangiectasia show decreased mitochondrial function
Journal of Clinical Investigation
2023 - Extending Peripheral Retinal Vascularization in Retinopathy of Prematurity Through Regulation of VEGF Signaling
American Journal of Ophthalmology
2023 - Macular Telangiectasia Type 2 versus Tamoxifen Retinopathy: How to Hit a Diagnostic Bullseye
Ophthalmology Retina
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Ali Bijani
Babol University of Medical Sciences
Hamid Asayesh
Ayatollah Boroujerdi University
John J. Huang
Isfahan University of Medical Sciences
Fotis Topouzis
National University of Singapore
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”